CIP, a Cardiac Isl1-Interacting Protein, Represses Cardiomyocyte Hypertrophy

Circulation Research - United States
doi 10.1161/circresaha.111.259663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

PICOT Is a Critical Regulator of Cardiac Hypertrophy and Cardiomyocyte Contractility

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2008English

Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance: Implications on Early Cardiac Remodeling

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Suppression of Proliferation and Cardiomyocyte Hypertrophy by CHAMP, a Cardiac-Specific RNA Helicase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Socking It to Cardiac Hypertrophy: STIM1-Mediated Ca2+ Entry in the Cardiomyocyte

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

SIRT1 Represses PKC-zeta Activity via Regulating Interplay of Acetylation and Phosphorylation in Cardiac Hypertrophy

British Journal of Pharmacology
Pharmacology
2018English

Cardiomyocyte-Specific Ablation of CD36 Accelerates the Progression From Compensated Cardiac Hypertrophy to Heart Failure

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2017English

Physiologic Cardiac Hypertrophy Corrects Contractile Protein Abnormalities Associated With Pathologic Hypertrophy in Rats.

Journal of Clinical Investigation
Medicine
1982English

G Protein-Coupled Receptor Kinase 2 Promotes Cardiac Hypertrophy

PLoS ONE
Multidisciplinary
2017English

Cardiomyocyte Proliferation, a Target for Cardiac Regeneration

Biochimica et Biophysica Acta - Molecular Cell Research
Cell BiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy